UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042853
Receipt number R000048898
Scientific Title A randomized, open-label, parallel-group study of the efficacy of oral Ninjin'yoeito in improving fatigability and nutritional status in the perioperative period of primary lung cancer
Date of disclosure of the study information 2021/03/01
Last modified on 2021/03/04 10:58:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of oral Ninjin'yoeito for improvement of fatigability and nutritional status in the perioperative period of primary lung cancer

Acronym

Efficacy of oral Ninjin'yoeito in the perioperative period of primary lung cancer

Scientific Title

A randomized, open-label, parallel-group study of the efficacy of oral Ninjin'yoeito in improving fatigability and nutritional status in the perioperative period of primary lung cancer

Scientific Title:Acronym

Efficacy of oral Ninjin'yoeito for improvement of fatigability and nutritional status in the perioperative period of primary lung cancer

Region

Japan


Condition

Condition

Lung cancer

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

A prospective study will be conducted to evaluate the efficacy of Ninjin'yoeito by administering Ninjin'yoeito in the perioperative period to patients aged 65 years or older who are scheduled for surgery for primary lung cancer, and comparing them with patients in the group that does not receive Ninjin'yoeito to subjectively and objectively evaluate the patients' nutritional status, fatigability, and recovery status.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Chalder Fatigue Scale before administration of Ninjin'yoeito, a month after surgery, and 6 months after surgery.

Key secondary outcomes

Cancer Fatigue Scale, Kihon Checklist (KCL), and Controlling nutrition status (COUNT)and Prognostic nutritional index(PNI) before administration of Ninjin'yoeito, a month after surgery, and 6 months after surgery.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Three packets of 3.0g (9.0g)of Ninjin'yoeito per day should be taken before or between meals. The dosage should be taken from 2 weeks before to 24 weeks after surgery for primary lung cancer.

Interventions/Control_2

Patients do not take Ninjin'yoeito.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients aged 65 years or older who will undergo anatomical lung resection and systematic lymph node dissection for primary lung cancer at our department.
2. Patients who have given written consent for this study.
3. Patients with primary lung cancer in stages 0, I, II and III.

Key exclusion criteria

1. The patient does not give consent to participate in the study.
2.The patient has a history of allergy to Ninjin'yoeito or its components.
3. The patient has severe anorexia, nausea, or vomiting, which is a cautious administration of the study drug.
4. The patient with severe hepatic or renal dysfunction.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hironori
Middle name
Last name Ishibashi

Organization

Tokyo Medical and Dental University

Division name

Department of Thoracic Surgery, Graduate school of Medical and Dental Sciences

Zip code

1138510

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

03-5803-4072

Email

hishiba.thsr@tmd.ac.jp


Public contact

Name of contact person

1st name Hironori
Middle name
Last name Ishibashi

Organization

Tokyo Medical and Dental University

Division name

Department of Thoracic Surgery, Graduate school of Medical and Dental Sciences

Zip code

1138510

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

03-5803-4072

Homepage URL


Email

hishiba.thsr@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical and Dental University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee, Faculty of Medicine, Tokyo Medical and Dental University

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

Tel

03-5803-5096

Email

syomu1.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2021 Year 03 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 12 Month 25 Day

Last modified on

2021 Year 03 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048898


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name